FSA and HSA for GLP-1 Medications: What Qualifies, What Doesn’t, and How to Use It

Flexible Spending Accounts and Health Savings Accounts exist to reduce the effective cost of qualified medical expenses through tax-exempt dollars. For patients paying out-of-pocket for GLP-1 medications, these accounts can translate to a 20–35% cost reduction depending on the individual’s marginal tax rate. The key question is whether the specific expense qualifies—and on that question, the rules require careful attention.

The Foundational Rule: Prescription Required, Purpose Matters

Prescription medications are generally eligible for FSA and HSA reimbursement when prescribed by a licensed physician for the treatment or prevention of a diagnosed medical condition. This is the governing principle under IRS Publication 502, which defines qualified medical expenses for these accounts.

The complication for GLP-1 medications is that the same drug may qualify or not qualify depending on the documented indication. A prescription for semaglutide to treat type 2 diabetes qualifies straightforwardly. A prescription for the same molecule at a weight-management dose qualifies when obesity or a documented comorbidity is the stated medical indication. A prescription written primarily to support general wellness or cosmetic weight loss, without a documented medical condition, sits in a more contested space.

In practice, the IRS does not audit individual FSA and HSA transactions at the line-item level for most patients. But in the event of an audit, the documentation required to support a GLP-1 reimbursement is a valid prescription from a licensed physician and evidence that the expense relates to a diagnosed medical condition. Patients whose GLP-1 prescriptions are for obesity (ICD-10: E66), prediabetes (R73.09), or type 2 diabetes (E11) are on solid footing. Those using telehealth programs should verify that their prescription documentation clearly states the medical indication.

FSA vs HSA: Key Structural Differences

FSAs and HSAs are not interchangeable, and the differences matter for anyone planning to use these accounts to offset GLP-1 costs over time.

Flexible Spending Accounts (FSAs)

FSAs are employer-sponsored accounts funded with pre-tax payroll contributions. They carry a “use it or lose it” provision: funds not used by the plan year deadline (with a grace period of up to 2.5 months, or rollover of up to $660 in 2026, depending on the plan) are forfeited. FSA funds are also not portable if you change employers.

The practical implication is that an FSA works well for anticipated, recurring expenses like ongoing GLP-1 medication costs, but requires planning. Contributing the expected annual GLP-1 cost to the FSA at the start of the year reduces taxable income by that amount and provides immediate access to the full annual contribution.

Health Savings Accounts (HSAs)

HSAs require enrollment in a High-Deductible Health Plan (HDHP). Unlike FSAs, HSA funds roll over indefinitely, can be invested, and remain with the account holder even after a change of employer or health plan. The investment growth within an HSA is tax-free when used for qualified medical expenses.

For patients on a GLP-1 who anticipate ongoing use and are enrolled in an HDHP, the HSA is often the more powerful instrument. Contributions made in years when GLP-1 costs are lower can be carried forward and drawn on when costs increase or when coverage changes. Some patients use HSAs strategically: they pay GLP-1 costs out-of-pocket now, retain receipts, and reimburse themselves later from the HSA after the account has grown through investment—a technique sometimes called “superfunding.”

Using FSA/HSA With Telehealth GLP-1 Programs

Patients accessing GLP-1 medications through telehealth platforms face a practical question: do the costs incurred through these programs qualify for FSA and HSA reimbursement?

The answer, in general, is yes—with conditions. The telehealth consultation fee qualifies as a physician visit expense. The medication cost qualifies as a prescription drug expense, provided the patient receives a valid prescription from the physician associated with the platform. Monthly program fees that bundle physician services and medication together may qualify in their entirety or may require itemization depending on the FSA or HSA administrator’s policies.

Not all FSA and HSA administrators apply the same standards. Some will reimburse a telehealth platform’s monthly membership fee without requiring itemization; others will request a letter of medical necessity or a pharmacy receipt. Patients should contact their FSA or HSA administrator directly before submitting a claim, particularly for bundled program fees, to understand what documentation will be required.

What Does Not Qualify

Several adjacent expenses do not qualify for FSA or HSA reimbursement and should not be submitted:

• Weight-loss programs that do not involve a licensed physician or diagnosis of obesity as a medical condition (gym memberships, commercial diet programs)
• Supplements or vitamins marketed for weight management, even those often used alongside GLP-1 therapy
• Compounded medications purchased without a valid prescription from a licensed physician
• Insurance premiums (with limited exceptions for HSA holders on Medicare or COBRA)
• Cosmetic procedures, even when motivated by weight-related goals

Practical Steps to Maximize Benefit

Patients planning to use pre-tax accounts to offset GLP-1 costs should approach this in an organized way. Begin by calculating the expected annual cost of the chosen program—physician fees, medication, and any monitoring costs—and compare that to the account contribution limits. For most patients on a mid-tier telehealth GLP-1 program at $200/month, the annual cost of approximately $2,400 falls within FSA and HSA contribution limits, making it possible to cover the entire expense with pre-tax dollars.

Retain all receipts and prescription documentation for FSA reimbursement. For HSA use, maintain records permanently, as the IRS allows account holders to reimburse themselves for qualified expenses incurred in any prior year, with no statute of limitations, provided the expense occurred after the HSA was established.

For patients considering a change to an HDHP to access HSA benefits, this decision requires weighing the higher deductible against the tax savings and long-term investment potential. For patients with significant ongoing medication costs, the calculation may favor the HDHP even with higher upfront exposure.